Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Simon Baldacci, Ph.D., M.D.

Title
Institution
Department
Address
Phone

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Giannico OV, Baldacci S, Desiante F, Basile FC, Franco E, Fragnelli GR, Diletti G, Conversano M. PCDD/Fs and PCBs in Mytilus galloprovincialis from a contaminated area in Italy: the role of mussel size, temperature and meteorological factors. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2022 Jun; 39(6):1123-1135. PMID: 35389328.
    Citations:    Fields:    Translation:Animals
  2. Baldacci S, Besse B, Avrillon V, Mennecier B, Mazieres J, Dubray-Longeras P, Cortot AB, Descourt R, Doubre H, Quantin X, Duruisseaux M, Monnet I, Moro-Sibilot D, Cadranel J, Clément-Duchêne C, Cousin S, Ricordel C, Merle P, Otto J, Schneider S, Langlais A, Morin F, Westeel V, Girard N. Lorlatinib for advanced anaplastic lymphoma kinase-positive non-small cell lung cancer: Results of the IFCT-1803 LORLATU cohort. Eur J Cancer. 2022 05; 166:51-59. PMID: 35278825.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  3. Giannico OV, Fragnelli GR, Baldacci S, Desiante F, Pellegrino A, Basile FC, Franco E, Diletti G, Conversano M. Dioxins and PCBs contamination in milk and dairy products from Province of Taranto (Puglia Region, Southern Italy): a six years spatio-temporal monitoring study. Ann Ist Super Sanita. 2021 Jul-Sep; 57(3):233-238. PMID: 34554117.
    Citations:    Fields:    Translation:HumansAnimalsPHPublic Health
  4. Vauléon E, Behal H, Lebellec L, Desbarbieux R, Baldacci S, Simon N, Pannier D, Vieillard MH, Turpin A. Does bevacizumab increase joint pain in patients with cancer? Results of the prospective observational BEVARTHRALGIA study. Cancer Chemother Pharmacol. 2021 04; 87(4):533-541. PMID: 33438069.
    Citations: 2     Fields:    Translation:Humans
  5. Giannico OV, Desiante F, Basile FC, Franco E, Baldacci S, Fragnelli GR, Diletti G, Conversano M. Dioxins and PCBs contamination in mussels from Taranto (Ionian Sea, Southern Italy): a seven years spatio-temporal monitoring study. Ann Ist Super Sanita. 2020 Oct-Dec; 56(4):452-461. PMID: 33346171.
    Citations: 1     Fields:    Translation:AnimalsPHPublic Health
  6. Baldacci S, Grégoire V, Patrucco E, Chiarle R, Jamme P, Wasielewski E, Descarpentries C, Copin MC, Awad MM, Cortot AB. Complete and prolonged response to anti-PD1 therapy in an ALK rearranged lung adenocarcinoma. Lung Cancer. 2020 08; 146:366-369. PMID: 32553554.
    Citations: 1     Fields:    Translation:Humans
  7. Jamme P, Fernandes M, Copin MC, Descarpentries C, Escande F, Morabito A, Grégoire V, Jamme M, Baldacci S, Tulasne D, Kherrouche Z, Cortot AB. Alterations in the PI3K Pathway Drive Resistance to MET Inhibitors in NSCLC Harboring MET Exon 14 Skipping Mutations. J Thorac Oncol. 2020 05; 15(5):741-751. PMID: 32169477.
    Citations: 21     Fields:    Translation:Humans
  8. Domblides C, Leroy K, Monnet I, Mazières J, Barlesi F, Gounant V, Baldacci S, Mennecier B, Toffart AC, Audigier-Valette C, Doucet L, Giroux-Leprieur E, Guisier F, Ricordel C, Molinier O, Perol M, Pichon E, Robinet G, Templement-Grangerat D, Ruppert AM, Rabbe N, Antoine M, Wislez M. Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma. J Thorac Oncol. 2020 05; 15(5):860-866. PMID: 31991225.
    Citations: 23     Fields:    Translation:Humans
  9. Baldacci S, Figeac M, Antoine M, Descarpentries C, Kherrouche Z, Jamme P, Copin MC, Tulasne D, Nanni I, Beau-Faller M, Melaabi S, Levallet G, Quoix E, Moro-Sibilot D, Friard S, Missy P, Barlesi F, Cadranel J, Cortot AB. High MET Overexpression Does Not Predict the presence of MET exon 14 Splice Mutations in NSCLC: Results From the IFCT PREDICT.amm study. J Thorac Oncol. 2020 01; 15(1):120-124. PMID: 31605799.
    Citations: 8     Fields:    Translation:Humans
  10. Loconsole D, De Robertis AL, Morea A, Casulli D, Mallamaci R, Baldacci S, Centrone F, Bruno V, Quarto M, Accogli M, Chironna M. High Public-Health Impact in an Influenza-B-Mismatch Season in Southern Italy, 2017-2018. Biomed Res Int. 2019; 2019:4643260. PMID: 31531353; PMCID: PMC6720359.
    Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
  11. Jamme P, Descarpentries C, Gervais R, Dansin E, Wislez M, Grégoire V, Richard N, Baldacci S, Rabbe N, Kyheng M, Kherrouche Z, Escande F, Copin MC, Cortot AB. Relevance of Detection of Mechanisms of Resistance to ALK Inhibitors in ALK-Rearranged NSCLC in Routine Practice. Clin Lung Cancer. 2019 07; 20(4):297-304.e1. PMID: 31147208.
    Citations: 7     Fields:    Translation:Humans
  12. Baldacci S, Kherrouche Z, Cockenpot V, Stoven L, Copin MC, Werkmeister E, Marchand N, Kyheng M, Tulasne D, Cortot AB. MET amplification increases the metastatic spread of EGFR-mutated NSCLC. Lung Cancer. 2018 11; 125:57-67. PMID: 30429039.
    Citations: 6     Fields:    Translation:HumansAnimalsCells
  13. Descarpentries C, Leprêtre F, Escande F, Kherrouche Z, Figeac M, Sebda S, Baldacci S, Grégoire V, Jamme P, Copin MC, Tulasne D, Cortot AB. Optimization of Routine Testing for MET Exon 14 Splice Site Mutations in NSCLC Patients. J Thorac Oncol. 2018 12; 13(12):1873-1883. PMID: 30195702.
    Citations: 8     Fields:    Translation:HumansCells
  14. Duplaquet L, Kherrouche Z, Baldacci S, Jamme P, Cortot AB, Copin MC, Tulasne D. The multiple paths towards MET receptor addiction in cancer. Oncogene. 2018 06; 37(24):3200-3215. PMID: 29551767.
    Citations: 16     Fields:    Translation:HumansAnimals
  15. Baldacci S, Mazieres J, Tomasini P, Girard N, Guisier F, Audigier-Valette C, Monnet I, Wislez M, Pérol M, Dô P, Dansin E, Leduc C, Giroux Leprieur E, Moro-Sibilot D, Tulasne D, Kherrouche Z, Labreuche J, Cortot AB. Outcome of EGFR-mutated NSCLC patients with MET-driven resistance to EGFR tyrosine kinase inhibitors. Oncotarget. 2017 12 01; 8(62):105103-105114. PMID: 29285237.
    Citations: 10     Fields:    
  16. Cortot AB, Kherrouche Z, Descarpentries C, Wislez M, Baldacci S, Furlan A, Tulasne D. Exon 14 Deleted MET Receptor as a New Biomarker and Target in Cancers. J Natl Cancer Inst. 2017 05 01; 109(5). PMID: 28376232.
    Citations: 28     Fields:    Translation:HumansAnimals
  17. Scherpereel A, Grigoriu BD, Noppen M, Gey T, Chahine B, Baldacci S, Trauet J, Copin MC, Dessaint JP, Porte H, Labalette M. Defect in recruiting effector memory CD8+ T-cells in malignant pleural effusions compared to normal pleural fluid. BMC Cancer. 2013 Jul 02; 13:324. PMID: 23816056.
    Citations: 16     Fields:    Translation:HumansCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Baldacci's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (87)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.